Home › Aortic Valve Stenosis › Pennsylvania › Philadelphia
Aortic Valve Stenosis clinical trials in Philadelphia, PA
5 studies for Aortic Valve Stenosis are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
RecruitingObservational study
- Lankenau Medical Center, Wynnewood · 7 mi away
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
RecruitingPhase 2/3
- University of Pennsylvania, Philadelphia
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
RecruitingPhase 2
- Perelman School of Medicine, Philadelphia
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Recruiting
- Lankenau Medical Center, Wynnewood · 7 mi away
PARTNER 3 Trial - Aortic Valve-in-Valve
Recruiting
- University of Pennsylvania Hospital, Philadelphia
- Lankenau Medical Center, Wynnewood · 7 mi away
Aortic Valve Stenosis trials in other cities
- Boston, MA10 studies
- San Francisco, CA9 studies
- New York City, NY9 studies
- Cleveland, OH8 studies
- Cincinnati, OH7 studies
- Houston, TX7 studies
- Mountain View, CA7 studies
- Pittsburgh, PA6 studies
- Rochester, MN6 studies
- Newark, NJ6 studies
- Los Angeles, CA6 studies
- Chicago, IL6 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.